Nano Science and Technology Institute - NSTI  
Nano Science and Technology Institute   Home | Subscribe | Site Map  
  ABOUT | COURSES | EVENTS | PUBLICATIONS | LEADERSHIP | OUTREACH | NEWS | PRESS | JOBS | Nanotechnology Solutions
px
px fade_top
Publications
Nanotech 2008 CDROM
Nanotech 2007 CDROM
Nanotech 2006 CDROM
Nanotech 2005 CDROM
Nanotech 2004 CDROM
3 CDROM Special Offer
Nanotech 2008 Vol. 1
Nanotech 2008 Vol. 2
Nanotech 2008 Vol. 3
Nanotech 2007 Vol. 1
Nanotech 2007 Vol. 2
Nanotech 2007 Vol. 3
Nanotech 2007 Vol. 4
Nanotech 2006 Vol. 1
Nanotech 2006 Vol. 2
Nanotech 2006 Vol. 3
Nanotech 2005 Vol. 1
Nanotech 2005 Vol. 2
Nanotech 2005 Vol. 3
WCM 2005
Nanotech 2004 Vol. 1
Nanotech 2004 Vol. 2
Nanotech 2004 Vol. 3
Nanotech 2003 Vol. 1
Nanotech 2003 Vol. 2
Nanotech 2003 Vol. 3
Nanotech 2002 Vol. 1
Nanotech 2002 Vol. 2
Nanotech 2001 Vol. 1
Nanotech 2001 Vol. 2
MSM 2000
MSM 99
MSM 98
Index of Authors
Index of Keywords
Index of Affiliations
Library Request Form
Shopping Cart
Order Form
 
Publications Publications
Nanotech 2006 Vol. 2
p
 
Technical Proceedings of the 2006 NSTI Nanotechnology Conference and Trade Show, Volume 2
Nanotech 2006 Vol. 2
Technical Proceedings of the 2006 NSTI Nanotechnology Conference and Trade Show, Volume 2
 
Chapter 1: Cancer Nanotechnology
 

Nano-structured Biodegradable Ceramics for the Prevention and Treatment of Bone Caner

Authors:G. Balasundaram and T.J. Webster
Affilation:PURDUE UNIVERSITY, US
Pages:61 - 62
Keywords:bone cancer, drug delivery, hydroxyapatite
Abstract:For people dying of some cancers such as breast and prostate, the spread of bone cancer is almost universal. Although current drug delivery systems have found a variety of uses in targeting certain forms of cancer, their suitability to treat bone cancer has not yet been demonstrated. In the present study, functionalized bioresorbable nano-materials (less than 50 nm in size) will be formulated to specifically attach to cancerous (not healthy) bone to form an implant used to treat bone cancer. After attachment, sustained release of the anti-cancer agents will then occur at targeted sites. Specifically, inorganic biodegradable nanomaterials (including ceramics like hydroxyapatite or HA) will be functionalized with anti-cancer drugs (such as doxorubicin using covalent chemical attachment). The outer coating of the embedded nanoparticle systems will also be created to have different biodegradation rates for the controlled release of anticancer agents to the target site. In this study, we provided the evidence of synthesizing highly degradable nano-amorphous calcium phosphate and slowly degradable nano-crystalline HA as drug delivery carriers to treat bone cancer.
ISBN:0-9767985-7-3
Pages:893
Hardcopy:$185.00
 
Order:Mail/Fax Form
Special:3 CD Set — 15% off with Free Shipping
Up
nanoPRwire™
nanoPRwire
News Headlines
nano World news
 
 
 
 
px
© Nano Science and Technology Institute     About NSTI | Terms of Use | Privacy Policy | Contact